One of the most pressing problems in transplant medicine is the shortage of available organ donors to keep up with high demand. What are the ethical considerations of solving the liver shortage problem with xenotransplantation? Host Dr. Aaron Carroll welcomes Drs. Tector and Helft for the second part in a discussion of xenotransplantation. Dr. Joseph Tector directs the section of transplant surgery's xenotransplantation research program at Indiana University Health. Dr. Paul Helft is director of the Charles Warren Fairbanks Center for Medical Ethics at Indiana University Health, and is a member of the IU Health Ethics Committee and co-chair of the IU Health Ethics Consultation Subcommittee.
Xenotransplantation: Liver Allocation and Bioethics Part 2 of 2

Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Overview
One of the most pressing problems in transplant medicine is the shortage of available organ donors to keep up with high demand. What are the ethical considerations of solving the liver shortage problem with xenotransplantation? Host Dr. Aaron Carroll welcomes Drs. Tector and Helft for the second part in a discussion of xenotransplantation. Dr. Joseph Tector directs the section of transplant surgery's xenotransplantation research program at Indiana University Health. Dr. Paul Helft is director of the Charles Warren Fairbanks Center for Medical Ethics at Indiana University Health, and is a member of the IU Health Ethics Committee and co-chair of the IU Health Ethics Consultation Subcommittee.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
Implementing a Multidisciplinary Approach to Heart Failure: Patient Identification and Treatment Using Novel Device Therapy
Advances in MASLD/MASH: Treating the Liver, the Disease, and the Patient – Chair’s Perspective
IgG4-RD Case Conversations: Diagnosing Pancreaticobiliary Manifestations and Ruling Out Malignancy
Updates From the 7th World Symposium Task Force
HF Management for Patients with Comorbid Conditions
Level Up Your Skills: Tailoring Management of HF
HER2 Testing: The Evolving Role of Immunohistochemistry (IHC)
First-line Chemotherapy Options in Metastatic PDAC
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?